项目 | 复发组(33例) | 未复发组(209例) | t/x2值 | P值 |
年龄 | 65.27 ± 9.77 | 62.51 ± 10.64 | 1.4 | 0.16 |
男性[例(%)] | 22 (66.7) | 130 (62.2) | 0.243 | 0.622 |
病史[例(%)] |
|
|
|
|
高血压 | 19 (57.6) | 104 (49.8) | 0.696 | 0.404 |
糖尿病 | 9 (27.3) | 35 (16.7) | 2.123 | 0.145 |
冠心病 | 14 (42.4) | 60 (28.7) | 2.526 | 0.112 |
卒中/短暂性脑缺血发作 | 5 (15.2) | 26 (12.4) | 0.188 | 0.665 |
吸烟[例(%)] | 11 (33.3) | 61 (29.2) | 0.634 | 0.628 |
饮酒[例(%)] | 7 (21.2) | 59 (28.2) | 0.708 | 0.4 |
用药情况[例(%)] |
|
|
|
|
胺碘酮 | 16 (48.5) | 131 (62.7) | 2.408 | 0.121 |
β受体阻滞剂 | 14 (42.4) | 48 (23.0) | 5.662 | 0.017 |
华法林 | 5 (15.2) | 17 (8.1) | 1.698 | 0.193 |
利伐沙班 | 28 (84.8) | 181 (86.6) | 0.074 | 0.785 |
心超指标 |
|
|
|
|
D1 | 43.88 ± 5.62 | 41.16 ± 5.26 | 2.735 | 0.007 |
D2 | 44.64 ± 6.17 | 41.27 ± 5.52 | 3.207 | 0.002 |
D3 | 62.27 ± 7.88 | 57.62 ± 7.43 | 3.316 | 0.001 |
D | 50.26 ± 6.01 | 46.68 ± 5.32 | 3.529 | 0.000 |
D1i | 24.41 ± 3.09 | 22.80 ± 3.17 | 2.726 | 0.007 |
D2i | 24.82 ± 3.32 | 22.86 ± 3.29 | 3.182 | 0.002 |
D3i | 34.63 ± 4.11 | 31.96 ± 4.76 | 3.041 | 0.003 |
LADi | 27.95 ± 3.19 | 25.87 ± 3.36 | 3.328 | 0.001 |